Inventor · disambiguated record
Thomas Muley
Also filed as: MULEY THOMAS
1 granted patent·6 pending applications·0 citations·filing 2007–2023
5Inventor score
Files withROCHE DIAGNOSTICS OPERATIONS INC3ROCHE SEQUENCING SOLUTIONS INC2ANGEL PETER1LADURNER ANDREAS1
Top patents by PatentIndex Score
7 records- 0148US2023358750A1Prognostic value of biomarkers in patients with non-small cell lung cancer having stable diseaseROCHE DIAGNOSTICS OPERATIONS INC·Filed 2023·Application pending·0 cites
- 0239US11402381B2Methods of identifying an individual to be treated by chemotherapy based on cytokeratin-19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) marker molecules and related usesROCHE DIAGNOSTICS OPERATIONS INC·Filed 2018·Granted Aug 2, 2022·0 cites·8 claims
- 0339US2010151588A1Means and methods for diagnosing and treating cancer based on the frmd3 geneANGEL PETER·Filed 2007·Application pending·0 cites
- 0434US2021054465A1Surrogate marker and method for tumor mutation burden measurementROCHE SEQUENCING SOLUTIONS INC·Filed 2019·Application pending·0 cites
- 0534US2021222251A1Method of cancer prognosis by assessing tumor variant diversityROCHE SEQUENCING SOLUTIONS INC·Filed 2019·Application pending·0 cites
- 0633US2018292410A1Methods of detecting a relapse of a lung adenocarcinoma based on marker human epididymis protein 4 (he4) and related usesROCHE DIAGNOSTICS OPERATIONS INC·Filed 2018·Application pending·0 cites
- 079US2012171225A1Diagnostic Method for Predicting the Risk of Cancer Recurrence Based on Histone Macroh2A IsoformsLADURNER ANDREAS·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thomas Muley files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →